HEADER TRANSFERASE 14-MAY-15 4ZTH TITLE STRUCTURE OF HUMAN P38AMAPK-ARYLPYRIDAZINYLPYRIDINE FRAGMENT COMPLEX TITLE 2 USED IN INHIBITOR DISCOVERY COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 14; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAPK 14,CYTOKINE SUPPRESSIVE ANTI-INFLAMMATORY DRUG-BINDING COMPND 5 PROTEIN,CSBP,MAP KINASE MXI2,MAX-INTERACTING PROTEIN 2,MITOGEN- COMPND 6 ACTIVATED PROTEIN KINASE P38 ALPHA,MAP KINASE P38 ALPHA,STRESS- COMPND 7 ACTIVATED PROTEIN KINASE 2A,SAPK2A; COMPND 8 EC: 2.7.11.24; COMPND 9 ENGINEERED: YES; COMPND 10 OTHER_DETAILS: HUMAN P38 ALPHA MAP KINASE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR V.L.GRUM-TOKARS,S.M.ROY,D.M.WATTERSON REVDAT 4 06-MAR-24 4ZTH 1 REMARK REVDAT 3 01-JAN-20 4ZTH 1 JRNL REVDAT 2 20-SEP-17 4ZTH 1 REMARK REVDAT 1 22-JUN-16 4ZTH 0 JRNL AUTH S.M.ROY,G.MINASOV,O.ARANCIO,L.W.CHICO,L.J.VAN ELDIK, JRNL AUTH 2 W.F.ANDERSON,J.C.PELLETIER,D.M.WATTERSON JRNL TITL A SELECTIVE AND BRAIN PENETRANT P38 ALPHA MAPK INHIBITOR JRNL TITL 2 CANDIDATE FOR NEUROLOGIC AND NEUROPSYCHIATRIC DISORDERS THAT JRNL TITL 3 ATTENUATES NEUROINFLAMMATION AND COGNITIVE DYSFUNCTION. JRNL REF J.MED.CHEM. V. 62 5298 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 30978288 JRNL DOI 10.1021/ACS.JMEDCHEM.9B00058 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 20253 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1036 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.21 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1450 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.25 REMARK 3 BIN R VALUE (WORKING SET) : 0.2640 REMARK 3 BIN FREE R VALUE SET COUNT : 64 REMARK 3 BIN FREE R VALUE : 0.3170 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2736 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 135 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.68 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.12000 REMARK 3 B22 (A**2) : -0.26000 REMARK 3 B33 (A**2) : -0.86000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.241 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.202 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.162 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.831 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.965 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2959 ; 0.016 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2835 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4034 ; 1.687 ; 1.980 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6520 ; 0.937 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 362 ; 3.978 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 137 ;35.887 ;24.161 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 513 ;13.175 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;14.927 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 446 ; 0.103 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3369 ; 0.027 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 698 ; 0.021 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1415 ; 3.353 ; 3.716 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1414 ; 3.352 ; 3.712 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1785 ; 4.850 ; 5.547 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1786 ; 4.849 ; 5.551 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1544 ; 3.821 ; 4.103 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1544 ; 3.809 ; 4.103 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2249 ; 5.976 ; 5.993 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 3538 ; 8.381 ;30.169 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 3510 ; 8.365 ;30.030 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 404 REMARK 3 ORIGIN FOR THE GROUP (A): 6.7770 3.6800 15.9980 REMARK 3 T TENSOR REMARK 3 T11: 0.0229 T22: 0.0592 REMARK 3 T33: 0.0825 T12: -0.0131 REMARK 3 T13: 0.0036 T23: 0.0305 REMARK 3 L TENSOR REMARK 3 L11: 1.4684 L22: 0.4711 REMARK 3 L33: 0.4071 L12: -0.1038 REMARK 3 L13: -0.0164 L23: -0.3391 REMARK 3 S TENSOR REMARK 3 S11: 0.1154 S12: -0.0125 S13: -0.0247 REMARK 3 S21: 0.0281 S22: -0.1005 S23: 0.0380 REMARK 3 S31: 0.0105 S32: 0.0419 S33: -0.0149 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4ZTH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-MAY-15. REMARK 100 THE DEPOSITION ID IS D_1000209781. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-APR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97872 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20253 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.19 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.65000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M AMMONIUM ACETATE, 0.1 BISTRIS (PH REMARK 280 5.5), 17% PEG 10,000, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.88350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.83450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.25050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 38.83450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.88350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.25050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -22 REMARK 465 HIS A -21 REMARK 465 HIS A -20 REMARK 465 HIS A -19 REMARK 465 HIS A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 SER A -15 REMARK 465 SER A -14 REMARK 465 GLY A -13 REMARK 465 VAL A -12 REMARK 465 ASP A -11 REMARK 465 LEU A -10 REMARK 465 GLY A -9 REMARK 465 THR A -8 REMARK 465 GLU A -7 REMARK 465 ASN A -6 REMARK 465 LEU A -5 REMARK 465 TYR A -4 REMARK 465 PHE A -3 REMARK 465 GLN A -2 REMARK 465 SER A -1 REMARK 465 ASN A 0 REMARK 465 ALA A 1 REMARK 465 SER A 2 REMARK 465 GLN A 3 REMARK 465 ALA A 172 REMARK 465 ARG A 173 REMARK 465 HIS A 174 REMARK 465 THR A 175 REMARK 465 ASP A 176 REMARK 465 ASP A 177 REMARK 465 GLU A 178 REMARK 465 MET A 179 REMARK 465 THR A 180 REMARK 465 GLY A 181 REMARK 465 TYR A 182 REMARK 465 ASP A 354 REMARK 465 GLN A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 MET A 358 REMARK 465 GLU A 359 REMARK 465 SER A 360 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP A 161 O HOH A 501 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 296 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 15 -24.79 78.70 REMARK 500 PHE A 99 107.51 -49.83 REMARK 500 ARG A 149 -10.31 75.36 REMARK 500 ASP A 150 40.06 -140.79 REMARK 500 ASP A 150 42.13 -140.79 REMARK 500 ASN A 201 -168.33 -111.84 REMARK 500 ASN A 201 -169.16 -111.84 REMARK 500 LEU A 289 50.95 -96.63 REMARK 500 REMARK 500 REMARK: NULL DBREF 4ZTH A 2 360 UNP Q16539 MK14_HUMAN 2 360 SEQADV 4ZTH MET A -22 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH HIS A -21 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH HIS A -20 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH HIS A -19 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH HIS A -18 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH HIS A -17 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH HIS A -16 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH SER A -15 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH SER A -14 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH GLY A -13 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH VAL A -12 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH ASP A -11 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH LEU A -10 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH GLY A -9 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH THR A -8 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH GLU A -7 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH ASN A -6 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH LEU A -5 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH TYR A -4 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH PHE A -3 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH GLN A -2 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH SER A -1 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH ASN A 0 UNP Q16539 EXPRESSION TAG SEQADV 4ZTH ALA A 1 UNP Q16539 EXPRESSION TAG SEQRES 1 A 383 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 383 GLY THR GLU ASN LEU TYR PHE GLN SER ASN ALA SER GLN SEQRES 3 A 383 GLU ARG PRO THR PHE TYR ARG GLN GLU LEU ASN LYS THR SEQRES 4 A 383 ILE TRP GLU VAL PRO GLU ARG TYR GLN ASN LEU SER PRO SEQRES 5 A 383 VAL GLY SER GLY ALA TYR GLY SER VAL CYS ALA ALA PHE SEQRES 6 A 383 ASP THR LYS THR GLY LEU ARG VAL ALA VAL LYS LYS LEU SEQRES 7 A 383 SER ARG PRO PHE GLN SER ILE ILE HIS ALA LYS ARG THR SEQRES 8 A 383 TYR ARG GLU LEU ARG LEU LEU LYS HIS MET LYS HIS GLU SEQRES 9 A 383 ASN VAL ILE GLY LEU LEU ASP VAL PHE THR PRO ALA ARG SEQRES 10 A 383 SER LEU GLU GLU PHE ASN ASP VAL TYR LEU VAL THR HIS SEQRES 11 A 383 LEU MET GLY ALA ASP LEU ASN ASN ILE VAL LYS CYS GLN SEQRES 12 A 383 LYS LEU THR ASP ASP HIS VAL GLN PHE LEU ILE TYR GLN SEQRES 13 A 383 ILE LEU ARG GLY LEU LYS TYR ILE HIS SER ALA ASP ILE SEQRES 14 A 383 ILE HIS ARG ASP LEU LYS PRO SER ASN LEU ALA VAL ASN SEQRES 15 A 383 GLU ASP CYS GLU LEU LYS ILE LEU ASP PHE GLY LEU ALA SEQRES 16 A 383 ARG HIS THR ASP ASP GLU MET THR GLY TYR VAL ALA THR SEQRES 17 A 383 ARG TRP TYR ARG ALA PRO GLU ILE MET LEU ASN TRP MET SEQRES 18 A 383 HIS TYR ASN GLN THR VAL ASP ILE TRP SER VAL GLY CYS SEQRES 19 A 383 ILE MET ALA GLU LEU LEU THR GLY ARG THR LEU PHE PRO SEQRES 20 A 383 GLY THR ASP HIS ILE ASP GLN LEU LYS LEU ILE LEU ARG SEQRES 21 A 383 LEU VAL GLY THR PRO GLY ALA GLU LEU LEU LYS LYS ILE SEQRES 22 A 383 SER SER GLU SER ALA ARG ASN TYR ILE GLN SER LEU THR SEQRES 23 A 383 GLN MET PRO LYS MET ASN PHE ALA ASN VAL PHE ILE GLY SEQRES 24 A 383 ALA ASN PRO LEU ALA VAL ASP LEU LEU GLU LYS MET LEU SEQRES 25 A 383 VAL LEU ASP SER ASP LYS ARG ILE THR ALA ALA GLN ALA SEQRES 26 A 383 LEU ALA HIS ALA TYR PHE ALA GLN TYR HIS ASP PRO ASP SEQRES 27 A 383 ASP GLU PRO VAL ALA ASP PRO TYR ASP GLN SER PHE GLU SEQRES 28 A 383 SER ARG ASP LEU LEU ILE ASP GLU TRP LYS SER LEU THR SEQRES 29 A 383 TYR ASP GLU VAL ILE SER PHE VAL PRO PRO PRO LEU ASP SEQRES 30 A 383 GLN GLU GLU MET GLU SER HET VVT A 401 19 HET GG5 A 402 18 HET BME A 403 4 HETNAM VVT 6-CHLORO-3-PHENYL-4-(PYRIDIN-4-YL)PYRIDAZINE HETNAM GG5 4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE HETNAM BME BETA-MERCAPTOETHANOL FORMUL 2 VVT C15 H10 CL N3 FORMUL 3 GG5 C14 H10 F N3 FORMUL 4 BME C2 H6 O S FORMUL 5 HOH *135(H2 O) HELIX 1 AA1 SER A 61 MET A 78 1 18 HELIX 2 AA2 LEU A 113 LYS A 118 1 6 HELIX 3 AA3 THR A 123 ALA A 144 1 22 HELIX 4 AA4 LYS A 152 SER A 154 5 3 HELIX 5 AA5 ALA A 184 ARG A 189 5 6 HELIX 6 AA6 ALA A 190 LEU A 195 1 6 HELIX 7 AA7 THR A 203 GLY A 219 1 17 HELIX 8 AA8 ASP A 227 GLY A 240 1 14 HELIX 9 AA9 GLY A 243 LYS A 248 1 6 HELIX 10 AB1 SER A 252 SER A 261 1 10 HELIX 11 AB2 ASN A 269 PHE A 274 1 6 HELIX 12 AB3 ASN A 278 LEU A 289 1 12 HELIX 13 AB4 ASP A 292 ARG A 296 5 5 HELIX 14 AB5 THR A 298 ALA A 304 1 7 HELIX 15 AB6 HIS A 305 ALA A 309 5 5 HELIX 16 AB7 ASP A 313 GLU A 317 5 5 HELIX 17 AB8 GLN A 325 ARG A 330 5 6 HELIX 18 AB9 LEU A 333 SER A 347 1 15 SHEET 1 AA1 2 PHE A 8 LEU A 13 0 SHEET 2 AA1 2 THR A 16 PRO A 21 -1 O THR A 16 N LEU A 13 SHEET 1 AA2 5 TYR A 24 SER A 32 0 SHEET 2 AA2 5 GLY A 36 ASP A 43 -1 O PHE A 42 N GLN A 25 SHEET 3 AA2 5 ARG A 49 LEU A 55 -1 O VAL A 52 N CYS A 39 SHEET 4 AA2 5 TYR A 103 HIS A 107 -1 O THR A 106 N ALA A 51 SHEET 5 AA2 5 ASP A 88 PHE A 90 -1 N ASP A 88 O VAL A 105 SHEET 1 AA3 3 ALA A 111 ASP A 112 0 SHEET 2 AA3 3 LEU A 156 VAL A 158 -1 O VAL A 158 N ALA A 111 SHEET 3 AA3 3 LEU A 164 ILE A 166 -1 O LYS A 165 N ALA A 157 CRYST1 65.767 74.501 77.669 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015205 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013423 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012875 0.00000